A multiple dose, double-blind, parallel, placebo controlled clinical trial to assess the efficacy and safety of once daily inhaled LAS 34273 200 µg given either in the morning or in the evening in patients with stable moderate to severe chronic obstructive pulmonary disease (COPD)